Literature DB >> 16024936

Presence of surfactant lamellar bodies in normal and diseased sinus mucosa.

Bradford A Woodworth1, Nancy Smythe, Samuel S Spicer, Bradley A Schulte, Rodney J Schlosser.   

Abstract

BACKGROUND: Pulmonary surfactant originates from phospholipid lamellar bodies secreted from the type II epithelial cell of the alveolus. In the lower airway, surfactant optimizes surface tension and oxygen exchange, decreases mucus viscosity and aids in mechanical elimination of inhaled pathogens. In addition to the lung, lamellar bodies have been identified in many other cell types throughout the human body. However, no prior studies have identified lamellar bodies in human sinus mucosa.
OBJECTIVES: We performed ultrastructural studies to assess whether lamellar bodies are present in the human sinus in a variety of diseased and normal epithelium.
METHODS: We biopsied sinus mucosa from 5 subjects, 1 each with allergic fungal sinusitis, eosinophilic mucin rhinosinusitis, cystic fibrosis, frontal sinus mucocele, and cerebrospinal fluid leak (healthy control). Mouse lung served as a positive control. Specimens were prepared using ferrocyanide-reduced osmium tetroxide and thiocarbohydrazide for fixation (R-OTO method) to avoid extraction of phospholipids during dehydration and were viewed with transmission electron microscopy.
RESULTS: We identified lamellar bodies in the sinus mucosa of all patients. Additionally, preservation of mouse lung lamellar bodies confirms that the R-OTO method is a valid technique to preserve these structures.
CONCLUSIONS: We describe a simpler, faster technique for identification of cellular phospholipid components than those used previously. Definitive identification of these lamellar bodies within ciliated pseudostratified epithelium of the upper airway indicates that surfactant may have a role in sinus function and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024936     DOI: 10.1159/000087093

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  3 in total

1.  Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33.

Authors:  Douglas D Reh; Yadong Wang; Murugappan Ramanathan; Andrew P Lane
Journal:  Am J Rhinol Allergy       Date:  2010 Mar-Apr       Impact factor: 2.467

2.  Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid.

Authors:  Thai Q Do; Safiehkhatoon Moshkani; Patricia Castillo; Suda Anunta; Adelina Pogosyan; Annie Cheung; Beth Marbois; Kym F Faull; William Ernst; Su Ming Chiang; Gary Fujii; Catherine F Clarke; Krishna Foster; Edith Porter
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

3.  Surfactant protein a expression in chronic rhinosinusitis and atrophic rhinitis.

Authors:  Mohammad Waheed El-Anwar; Atef A Hamed; Abd ElRaof Said Mohamed; Ahmad Abdel-Fattah Nofal; Maha A Mohamed; Hesham R Abdel-Aziz
Journal:  Int Arch Otorhinolaryngol       Date:  2015-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.